SinoMab BioScience Limited (HKG:3681)

SinoMab BioScience Revenue

SinoMab BioScience had revenue of 9.78M CNY in the half year ending June 30, 2025, with 15.50% growth. This brings the company's revenue in the last twelve months to 5.73M. In the year 2024, SinoMab BioScience had annual revenue of 2.03M with 48.42% growth.

• Revenue (ttm): 5.73M CNY
• Revenue Growth: +48.42%
• P/S Ratio: 417.61
• Revenue / Employee: 93.89K CNY
• Employees: 61
• Market Cap: 2.62B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.03M	661.00K	48.42%
Dec 31, 2023	1.37M	-2.67M	-66.15%
Dec 31, 2022	4.03M	-22.63M	-84.87%
Dec 31, 2021	26.66M	13.90M	108.91%
Dec 31, 2020	12.76M	-	-